Automated description from the Alliance of Genome Resources
Predicted to have RNA polymerase II activating transcription factor binding activity; identical protein binding activity; and phosphotyrosine residue binding activity. Involved in several processes, including animal organ development; cell surface receptor signaling pathway; and nervous system development. Localizes to the extrinsic component of postsynaptic membrane; neuromuscular junction; and protein-containing complex. Used to study DiGeorge syndrome and velocardiofacial syndrome. Human ortholog(s) of this gene implicated in chronic myeloid leukemia. Orthologous to human CRKL (CRK like proto-oncogene, adaptor protein).